Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis

BACKGROUND AND AIM: Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cirrhosis (PBC), but not all cases respond well. Evidence has shown that combination therapy of UDCA with bezafibrate significantly improved liver function. A meta-analysis was performed to assess the effic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drug Des Devel Ther
Главные авторы: Yin, Qin, Li, Jingjing, Xia, Yujing, Zhang, Rong, Wang, Jianrong, Lu, Wenxia, Zhou, Yuqing, Zheng, Yuanyuan, Abudumijiti, Huerxidan, Chen, Rongxia, Chen, Kan, Li, Sainan, Liu, Tong, Wang, Fan, Lu, Jie, Zhou, Yingqun, Guo, Chuanyong
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2015
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599574/
https://ncbi.nlm.nih.gov/pubmed/26491252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S92041
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы